KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to $10.7 million.

  • Medpace Holdings' Capital Expenditures rose 167.03% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.5 million, marking a year-over-year decrease of 1138.57%. This contributed to the annual value of $36.5 million for FY2024, which is 27.29% down from last year.
  • As of Q3 2025, Medpace Holdings' Capital Expenditures stood at $10.7 million, which was up 167.03% from $6.1 million recorded in Q2 2025.
  • Over the past 5 years, Medpace Holdings' Capital Expenditures peaked at $12.9 million during Q2 2024, and registered a low of $5.5 million during Q1 2024.
  • Its 5-year average for Capital Expenditures is $8.7 million, with a median of $9.1 million in 2021.
  • Per our database at Business Quant, Medpace Holdings' Capital Expenditures surged by 8641.81% in 2022 and then crashed by 5250.56% in 2025.
  • Medpace Holdings' Capital Expenditures (Quarter) stood at $9.1 million in 2021, then increased by 1.39% to $9.2 million in 2022, then increased by 8.04% to $10.0 million in 2023, then fell by 23.46% to $7.6 million in 2024, then surged by 40.17% to $10.7 million in 2025.
  • Its Capital Expenditures was $10.7 million in Q3 2025, compared to $6.1 million in Q2 2025 and $10.0 million in Q1 2025.